Zomedica Corp. (ZOMDF)
0.0789
0.00 (0.00%)
USD |
OTCM |
Oct 02, 16:00
Zomedica Gross Profit Margin (Quarterly) : 63.51% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.51% |
| March 31, 2026 | 62.33% |
| December 31, 2025 | 55.13% |
| September 30, 2025 | 67.15% |
| June 30, 2025 | 67.00% |
| March 31, 2025 | 50.77% |
| December 31, 2024 | 70.27% |
| September 30, 2024 | 43.33% |
| June 30, 2024 | 38.90% |
| March 31, 2024 | 65.75% |
| December 31, 2023 | 43.66% |
| Date | Value |
|---|---|
| September 30, 2023 | 43.58% |
| June 30, 2023 | 42.84% |
| March 31, 2023 | 45.09% |
| December 31, 2022 | 49.73% |
| September 30, 2022 | 50.40% |
| June 30, 2022 | 51.95% |
| March 31, 2022 | 51.77% |
| December 31, 2021 | 54.72% |
| September 30, 2021 | -456.0% |
| June 30, 2021 | -768.8% |
| March 31, 2021 | -675.2% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomerica, Inc. | -8.11% |
| Univec, Inc. | 9.05% |
| Lantheus Holdings, Inc. | 62.30% |
| IDEXX Laboratories, Inc. | 64.07% |
| Neogen Corp. | 37.59% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -16.37% |
| Return on Assets | -14.94% |
| Return on Invested Capital | -16.07% |
| Profit Margin (Quarterly) | -39.58% |
| Operating Margin (Quarterly) | -42.92% |
| Return on Net Operating Assets | -26.25% |